Ferritin oxidation and proteasomal degradation: Protection by antioxidants
暂无分享,去创建一个
Tilman Grune | Daniela Kiekebusch | Peter Voss | T. Grune | Manuela Jakstadt | P. Voss | L. Horakova | Lubica Horakova | Daniela Kiekebusch | M. Jakstadt
[1] B. Friguet,et al. Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.
[2] C. Winterbourn,et al. Protein carbonyl measurement by a sensitive ELISA method. , 1997, Free radical biology & medicine.
[3] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[4] B. Friguet,et al. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. , 1994, The Journal of biological chemistry.
[5] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] E. Stadtman,et al. Recent advances in the analysis of oxidized proteins , 2003, Amino Acids.
[7] Q. Peng,et al. Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury. , 2000, Biological & pharmaceutical bulletin.
[8] K. Davies,et al. 4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease* , 2000, Cellular and Molecular Life Sciences CMLS.
[9] J. Cummings,et al. Huntington's disease. , 1997, The Psychiatric clinics of North America.
[10] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[11] Patrizia Mecocci,et al. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.
[12] H. Sies,et al. Antioxidant action of stobadine. , 1994, Methods in enzymology.
[13] A. Bruce-Keller,et al. Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival* , 2002, The Journal of Biological Chemistry.
[14] R. Levine. Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. , 1983, The Journal of biological chemistry.
[15] H. Griffiths,et al. The presence of ascorbate induces expression of brain derived neurotrophic factor in SH‐SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival , 2005, Proteomics.
[16] B. Friguet,et al. Age-related impairment of mitochondrial matrix aconitase and ATP-stimulated protease in rat liver and heart. , 2004, European journal of biochemistry.
[17] K. Davies,et al. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.
[18] K. Davies,et al. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II—aging of nondividing cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] T. Grune,et al. Ferritin Oxidation in Vitro: Implication of Iron Release and Degradation by the 20S Proteasome , 2000, IUBMB life.
[20] J. Sastre,et al. A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. , 1998, Free radical biology & medicine.
[21] W. Bors,et al. Radical Functions in vivo: A Critical Review of Current Concepts and Hypotheses , 1998, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[22] D. Dearborn,et al. Protein labeling by reductive methylation with sodium cyanoborohydride: effect of cyanide and metal ions on the reaction. , 1980, Analytical biochemistry.
[23] R. Dean,et al. Stable markers of oxidant damage to proteins and their application in the study of human disease. , 1999, Free radical biology & medicine.
[24] W. Markesbery,et al. Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.
[25] Aaron Ciechanover,et al. The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.
[26] O. Aruoma,et al. An evaluation of the antioxidant and potential pro-oxidant properties of food additives and of trolox C, vitamin E and probucol. , 1990, Free radical research communications.
[27] J. Drapier,et al. Modulation of Iron Regulatory Protein Functions , 1996, The Journal of Biological Chemistry.
[28] B. Friguet,et al. Age-dependent protein modifications and declining proteasome activity in the human lens. , 2004, Archives of biochemistry and biophysics.
[29] E. Stadtman,et al. Oxidation of methionine residues of proteins: biological consequences. , 2003, Antioxidants & redox signaling.
[30] E. Stadtman,et al. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.
[31] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[32] M. Hentze,et al. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Schmitt,et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment , 2005, Neurology.
[34] H. Griffiths,et al. The effects of vitamin C supplementation on protein oxidation in healthy volunteers. , 2000, Biochemical and biophysical research communications.
[35] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[36] P. Mecocci,et al. Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia , 2004, Dementia and Geriatric Cognitive Disorders.
[37] G. Rimbach,et al. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. , 1999, Free radical biology & medicine.
[38] K. Davies,et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[40] E. Stadtman,et al. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. , 1989, The Journal of biological chemistry.
[41] T. Reinheckel,et al. Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.
[42] T. Reinheckel,et al. Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] T. Grune,et al. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. , 2005, Free radical biology & medicine.
[44] R. Floyd,et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. B. Martin,et al. Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.
[46] N. Chondrogianni,et al. Protein degradation during aging: The lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems , 2004, Biogerontology.
[47] E. Stadtman,et al. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins , 2003, Amino Acids.
[48] G. Bartosz,et al. Oxidative modifications of protein structures. , 2000, Advances in clinical chemistry.
[49] Y. Sagara,et al. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.
[50] C. Rice-Evans,et al. Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.
[51] K. Davies,et al. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. , 1993, The Journal of biological chemistry.
[52] R. Hough,et al. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. , 1987, The Journal of biological chemistry.
[53] Jeffrey N Keller,et al. The proteasome in brain aging , 2002, Ageing Research Reviews.
[54] H. Sies,et al. Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen. , 1992, Chemical research in toxicology.
[55] E. Aylward,et al. Does CAG repeat number predict the rate of pathological changes in Huntington's disease? , 1998, Annals of neurology.
[56] L. Packer,et al. Antioxidant action of Ginkgo biloba extract EGb 761. , 1994, Methods in enzymology.
[57] K. Davies,et al. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I— effects of proliferative senescence , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] T. Reinheckel,et al. Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress , 1995, The Journal of Biological Chemistry.
[59] B. Friguet,et al. Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.
[60] M. Ebadi,et al. Oxidative stress and antioxidant therapy in Parkinson's disease , 1996, Progress in Neurobiology.
[61] T. Reinheckel,et al. Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome. , 1999, Free radical biology & medicine.
[62] E. Stadtman,et al. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[63] P. Lasch,et al. Hydrogen Peroxide-induced Structural Alterations of RNase A* , 2001, The Journal of Biological Chemistry.
[64] Y. Christen,et al. What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.
[65] L. Beneš,et al. Pyridoindole stobadine is a potent scavenger of hydroxyl radicals , 1991, FEBS letters.
[66] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[67] S. Stolc,et al. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. , 1998, General pharmacology.
[68] E. Stadtman,et al. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. , 1993, The Journal of biological chemistry.
[69] E. Stadtman,et al. Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.
[70] B Daneshvar H Frandsen H Autrupand L O Dragsted. γ-Glutamyl semialdehyde and 2-amino-adipic semialdehyde: biomarkers of oxidative damage to proteins. , 1997, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[71] A. Rego,et al. Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. , 2001, Biochemical pharmacology.
[72] T. Grune,et al. Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.
[73] L. Packer,et al. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. , 1994, Methods in enzymology.
[74] T. Reinheckel,et al. Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.
[75] R. Nitsch,et al. Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.
[76] J. Gee,et al. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. , 2004, The international journal of biochemistry & cell biology.
[77] B. Friguet,et al. Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. , 2005, Biochimica et biophysica acta.
[78] Q. Peng,et al. Pycnogenol protects vascular endothelial cells from β-amyloid-induced injury. , 2000 .
[79] S. Aust,et al. Ferritin and superoxide-dependent lipid peroxidation. , 1985, The Journal of biological chemistry.
[80] Jeffrey N Keller,et al. Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.
[81] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[82] K. Davies,et al. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.
[83] C. Ross,et al. Neurobiology of Huntington's Disease , 1996, Neurobiology of Disease.
[84] K. Stettmaier,et al. Arguments against the significance of the Fenton reaction contributing to signal pathways under in vivo conditions , 2000, Free radical research.
[85] M. Davies,et al. Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products. , 2004, Free radical biology & medicine.
[86] V. Zelník,et al. N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[87] R. Levine. Carbonyl modified proteins in cellular regulation, aging, and disease. , 2002, Free radical biology & medicine.
[88] J. Connor,et al. A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.
[89] B. Friguet,et al. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[90] K. Davies,et al. Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome* , 1998, The Journal of Biological Chemistry.
[91] Carine Nizard,et al. Algae Extract Protection Effect on Oxidized Protein Level in Human Stratum Corneum , 2004, Annals of the New York Academy of Sciences.
[92] F. Walker. Huntington's disease , 2007, The Lancet.
[93] P. Harrison,et al. The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.
[94] Q. Peng,et al. Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. , 1999, General pharmacology.
[95] J. Williams,et al. Determination of carbonyl groups in oxidized proteins. , 2000, Methods in molecular biology.
[96] T. Grune,et al. Protein oxidation and proteolysis in RAW264.7 macrophages: effects of PMA activation. , 2001, Biochimica et biophysica acta.
[97] P. Rohdewald,et al. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. , 2002, International journal of clinical pharmacology and therapeutics.
[98] K. Davies,et al. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.